We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
BASi Opens new Facility in Europe to Better Serve Pharmaceutical and Biotech Companies
News

BASi Opens new Facility in Europe to Better Serve Pharmaceutical and Biotech Companies

BASi Opens new Facility in Europe to Better Serve Pharmaceutical and Biotech Companies
News

BASi Opens new Facility in Europe to Better Serve Pharmaceutical and Biotech Companies

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "BASi Opens new Facility in Europe to Better Serve Pharmaceutical and Biotech Companies"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

BASi has opened a new European laboratory and office in Warwickshire, UK. The relocation to a new, upgraded facility with expanded laboratories provides clients with enhanced capabilities throughout Europe.

Like its North American counterparts, the new 10,000 square foot facility offers a comprehensive bioanalytical capability, as well as providing access to the BASi Group’s full range of preclinical and pharmaceutical analysis services for pharmaceutical and biotechnology companies.

BASi Europe also supplies the complete line of BASi instruments and equipment, including the Culex Automated In Vivo Sampling System, as well as providing support for customers and distributors throughout Europe.

“BASi Europe offers over a thousand established and validated analytical methods and procedures,” said Mark Wareing, managing director of BASi Europe.

“We currently have multiple industry standard LC-MS/MS stations, as well as LC-EC and other analytical technologies, and we have invested in two more high-sensitivity MS/MS instruments with state-of-the-art front-end analytical systems. We offer complete peace of mind with an enviable track record of delivering internationally compliant GLP/GCP regulated studies.”
Advertisement